Formaldehyde-Free Microcapsule Shell via Crosslinking Agent
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing microcapsules with melamine formaldehyde shells face challenges in reducing remnant free formaldehyde levels, which can affect thermal stability and leakage of core materials, despite the use of formaldehyde scavengers like urea.
Innovation Solution
Incorporating a crosslinking agent, a reaction product of cyclic urea and a multifunctional aldehyde, into the emulsion before adding the melamine formaldehyde prepolymer to form microcapsules, which reduces initial and long-term free formaldehyde levels while maintaining thermal and mechanical stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If melamine formaldehyde resin is used as shell material, then thermal stability and mechanical strength are improved, but remnant free formaldehyde levels increase
Solution Approach 1:
The patent removes the harmful formaldehyde byproduct from the system by using alternative crosslinking agents (isocyanates, epoxides, carbodiimides, silanes, or cyanuric chloride) that do not generate free formaldehyde during the shell formation process, thereby extracting the harmful element while maintaining the beneficial structural properties of melamine formaldehyde resin
Solution Approach 2:
The patent introduces intermediary crosslinking agents that mediate between the melamine and formaldehyde components, providing the necessary crosslinking function without generating free formaldehyde. These intermediaries (such as isocyanates, epoxides, or cyanuric chloride) replace the direct melamine-formaldehyde crosslinking reaction that produces harmful byproducts
2Object-generated harmful factors
If formaldehyde scavengers like urea are added, then free formaldehyde levels are reduced, but thermal stability and shell morphology are compromised
Solution Approach 1:
The patent changes the chemical parameters of the crosslinking process by selecting alternative crosslinking agents with different chemical properties that do not interfere with the thermal stability or shell morphology, while still achieving the goal of reducing free formaldehyde through mechanisms other than scavenging
3Object-generated harmful factors
If crosslinking agent is added before melamine formaldehyde prepolymer, then free formaldehyde levels are reduced, but process complexity increases
Solution Approach 1:
The patent applies preliminary action by pre-mixing the crosslinking agent with the emulsion before adding the melamine formaldehyde prepolymer, allowing the crosslinking agent to be in position and ready to react, which simplifies the overall process compared to adding multiple agents at different stages
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method results in microcapsules with significantly reduced free formaldehyde levels, preserving thermal stability and phase change behavior, allowing for their use without modification in downstream applications.
Implementation Method 1
adding a crosslinking agent that is a reaction product of a cyclic urea and a multifunctional aldehyde to the aqueous emulsion prior to the addition of the melamine formaldehyde resin
Implementation Method 2
Melamine-formaldehyde (MF) microcapsules can be prepared by the in situ polymerization process of polycondensation
Implementation Method 3
Emulsion polymerization occurs in a water/oil or oil/water mixed phase
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Methods for producing microcapsules begin by preparing an emulsion of a surfactant, core material, and water, followed by the addition of a crosslinking agent and a melamine formaldehyde prepolymer, which is subsequently polymerized. The crosslinking agent is added before the melamine formaldehyde prepolymer, with a first addition or a second addition of a melamine formaldehyde prepolymer, or is divided for addition with both a first addition and a second addition of melamine formaldehyde prepolymer. The crosslinking agent is a mixture of a reaction product of a cyclic urea (U) and a multifunctional aldehyde (A), and at least one crosslinker selected from the following group: a reaction products of (i) an aminotriazine and at least one aldehyde selected from the group consisting of aliphatic monoaldehydes and multifunctional aliphatic aldehydes, (ii) urea and/or cyclic ureas and formaldehyde, or (iii) phenols and aliphatic monoaldehydes, or from alkoxycarbonylaminotriazines, or multifunctional isocyanates, epoxides, aziridines, and carbodiimides.